Canada Deep Brain Stimulation Devices Market Size & Outlook
Canada deep brain stimulation devices market, 2018-2030 (US$M)
Related Markets
Canada deep brain stimulation devices market highlights
- The Canada deep brain stimulation devices market generated a revenue of USD 84.6 million in 2024 and is expected to reach USD 150.9 million by 2030.
- The Canada market is expected to grow at a CAGR of 10.3% from 2025 to 2030.
- In terms of segment, dystonia was the largest revenue generating application in 2024.
- Epilepsy is the most lucrative application segment registering the fastest growth during the forecast period.
Deep brain stimulation devices market data book summary
| Market revenue in 2024 | USD 84.6 million |
| Market revenue in 2030 | USD 150.9 million |
| Growth rate | 10.3% (CAGR from 2025 to 2030) |
| Largest segment | Dystonia |
| Fastest growing segment | Epilepsy |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Other key industry trends
- In terms of revenue, Canada accounted for 6.0% of the global deep brain stimulation devices market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. deep brain stimulation devices market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 150.9 million by 2030.
Dystonia was the largest segment with a revenue share of 70.57% in 2024. Horizon Databook has segmented the Canada deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
In Canada, deep brain stimulation devices market is mainly driven by rising incidence of mental disorders. Moreover, approximately 2% of the population has obsessive compulsive disorder, according to Canadian Psychological Association. In addition, frequent approvals of deep brain stimulation devices by Health Canada are anticipated to promote the market growth in this country.
For instance, in June 2017, Medtronic received Health Canada license for its SureTune3 software for deep brain stimulation devices. Increasing preference for epilepsy specialists for deep brain stimulation devices therapy and rising number of epilepsy specialty centers are also key factors boosting demand for deep brain stimulation devices.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Deep Brain Stimulation Devices Market Scope
Deep Brain Stimulation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada deep brain stimulation devices market size, by application, 2018-2030 (US$M)
Canada Deep Brain Stimulation Devices Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
